Featured Events
TUCC's Classes & Support Groups, Events, Research, Urology News & More
Enzalutamide versus Bicalutamide in castration-resistant prostate cancer: The STRIVE Trial
TUCC physician, Lawrence Karsh, M.D., was a lead principal investigator in this international clinical trial, published in The Journal of Clinical Oncology in January 2016. Read Article
Read More